These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17622527)

  • 1. HLA-DPB1 supertype-associated protection from childhood leukaemia: relationship to leukaemia karyotype and implications for prevention.
    Taylor M; Harrison C; Eden T; Birch J; Greaves M; Lightfoot T; Hussain A;
    Cancer Immunol Immunother; 2008 Jan; 57(1):53-61. PubMed ID: 17622527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
    Peter A; Heiden T; Taube T; Körner G; Seeger K
    Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong association of the HLA-DP6 supertype with childhood leukaemia is due to a single allele, DPB1*0601.
    Taylor GM; Hussain A; Verhage V; Thompson PD; Fergusson WD; Watkins G; Lightfoot T; Harrison CJ; Birch JM;
    Leukemia; 2009 May; 23(5):863-9. PubMed ID: 19148140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukemia: an interphase FISH analysis.
    Attarbaschi A; Mann G; König M; Dworzak MN; Trebo MM; Mühlegger N; Gadner H; Haas OA;
    Leukemia; 2004 Oct; 18(10):1611-6. PubMed ID: 15356655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines.
    Uphoff CC; MacLeod RA; Denkmann SA; Golub TR; Borkhardt A; Janssen JW; Drexler HG
    Leukemia; 1997 Mar; 11(3):441-7. PubMed ID: 9067587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
    Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-positive leukemia.
    Gandemer V; Rio AG; de Tayrac M; Sibut V; Mottier S; Ly Sunnaram B; Henry C; Monnier A; Berthou C; Le Gall E; Le Treut A; Schmitt C; Le Gall JY; Mosser J; Galibert MD
    BMC Genomics; 2007 Oct; 8():385. PubMed ID: 17956600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preleukemic TEL-AML1-positive clones at cell level of 10(-3) to 10(-4) do not persist into adulthood.
    Olsen M; Madsen HO; Hjalgrim H; Gregers J; Rostgaard K; Schmiegelow K
    J Pediatr Hematol Oncol; 2006 Nov; 28(11):734-40. PubMed ID: 17114960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value.
    Codrington R; O'Connor HE; Jalali GR; Carrara P; Papaioannou M; Hart SM; Hoffbrand AV; Potter M; Prentice HG; Harrison CJ; Foroni L
    Br J Haematol; 2000 Dec; 111(4):1071-9. PubMed ID: 11167742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytogenetic and FISH findings are complementary in childhood ALL].
    Haltrich I; Csóka M; Kovács G; Fekete G
    Magy Onkol; 2008 Sep; 52(3):283-91. PubMed ID: 18845499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AML1 gene over-expression in childhood acute lymphoblastic leukemia.
    Mikhail FM; Serry KA; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Coignet L; Nucifora G
    Leukemia; 2002 Apr; 16(4):658-68. PubMed ID: 11960347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-existence of multiple subclones in TEL-AML1 at diagnosis of acute lymphoblastic leukaemia in association with submicroscopic deletion of AML1.
    Rothman R; Trakhtenbrot L; Bielorai B; Izraeli S; Ishoev G; Amariglio N; Rechavi G; Toren A
    Br J Haematol; 2005 May; 129(4):491-8. PubMed ID: 15877731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
    Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
    Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of the TEL-AML1 chromosomal translocation with the accumulation of methotrexate polyglutamates in lymphoblasts and with ploidy in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Whitehead VM; Payment C; Cooley L; Lauer SJ; Mahoney DH; Shuster JJ; Vuchich MJ; Bernstein ML; Look AT; Pullen DJ; Camitta B
    Leukemia; 2001 Jul; 15(7):1081-8. PubMed ID: 11455977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETV6 (TEL)-AML1 pre-B acute lymphoblastic leukaemia cells are associated with a distinct antigen-presenting phenotype.
    Alessandri AJ; Reid GS; Bader SA; Massing BG; Sorensen PH; Schultz KR
    Br J Haematol; 2002 Feb; 116(2):266-72. PubMed ID: 11841426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
    Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM
    J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of TEL and AML1 genes in the pathogenesis of hematologic malignancies].
    Zuna J
    Cas Lek Cesk; 2001 Mar; 140(5):131-7. PubMed ID: 11347199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between HLA-DP supertype and survival in childhood acute lymphoblastic leukaemia: evidence for selective loss of immunological control of residual disease?
    Taylor GM; Richards S; Wade R; Hussain A; Simpson J; Hill F; Mitchell C; Eden T;
    Br J Haematol; 2009 Apr; 145(1):87-95. PubMed ID: 19183185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of additional genetic events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: a molecular cytogenetics study.
    Ma SK; Wan TS; Cheuk AT; Fung LF; Chan GC; Chan SY; Ha SY; Chan LC
    Leukemia; 2001 Sep; 15(9):1442-7. PubMed ID: 11516105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan.
    Lin PC; Chang TT; Lin SR; Chiou SS; Jang RC; Sheen JM
    Kaohsiung J Med Sci; 2008 Jun; 24(6):289-96. PubMed ID: 18635414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.